BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 10892852)

  • 1. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
    Lip PL; Belgore F; Blann AD; Hope-Ross MW; Gibson JM; Lip GY
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2115-9. PubMed ID: 10892852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor and its receptor, Flt-1, in the plasma of patients with coronary or peripheral atherosclerosis, or Type II diabetes.
    Blann AD; Belgore FM; McCollum CN; Silverman S; Lip PL; Lip GY
    Clin Sci (Lond); 2002 Feb; 102(2):187-94. PubMed ID: 11834138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor and its receptor, Flt-1, in smokers and non-smokers.
    Belgore FM; Lip GY; Blann AD
    Br J Biomed Sci; 2000; 57(3):207-13. PubMed ID: 11050771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.
    Lip PL; Chatterjee S; Caine GJ; Hope-Ross M; Gibson J; Blann AD; Lip GY
    Br J Ophthalmol; 2004 Dec; 88(12):1543-6. PubMed ID: 15548809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of free and complexed soluble vascular endothelial growth factor receptor, Flt-1, in fluid samples: development and application of two new immunoassays.
    Belgore FM; Blann AD; Lip GY
    Clin Sci (Lond); 2001 May; 100(5):567-75. PubMed ID: 11294698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of vascular endothelial growth factor (VEGF) and its receptor, Flt-1, in haematological cancers: a comparison with breast cancer.
    Belgore FM; Lip GY; Bareford D; Wadley M; Stonelake P; Blann AD
    Am J Hematol; 2001 Jan; 66(1):59-61. PubMed ID: 11426496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment.
    Mohan JS; Lip PL; Blann AD; Bareford D; Lip GY
    Br J Ophthalmol; 2005 Jul; 89(7):815-9. PubMed ID: 15965157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor and tissue factor in patients with established peripheral artery disease: a link between angiogenesis and thrombogenesis?
    Makin AJ; Chung NA; Silverman SH; Lip GY
    Clin Sci (Lond); 2003 Apr; 104(4):397-404. PubMed ID: 12653684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
    Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
    Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble vascular endothelial growth factor, soluble VEGF receptor Flt-1 and endothelial function in healthy smokers.
    Schmidt-Lucke C; Belgore F; Reinhold D; Ansorge S; Klein HU; Schmidt-Lucke JA; Lip GY
    Int J Cardiol; 2005 Apr; 100(2):207-12. PubMed ID: 15823626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.
    Aiello LP; Avery RL; Arrigg PG; Keyt BA; Jampel HD; Shah ST; Pasquale LR; Thieme H; Iwamoto MA; Park JE
    N Engl J Med; 1994 Dec; 331(22):1480-7. PubMed ID: 7526212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of retinal coagulation status on oxidative metabolite and VEGF in 208 patients with proliferative diabetic retinopathy].
    Augustin AJ; Keller A; Koch F; Jurklies B; Dick B
    Klin Monbl Augenheilkd; 2001 Feb; 218(2):89-94. PubMed ID: 11258131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene transfer of a soluble receptor of VEGF inhibits the growth of experimental eyelid malignant melanoma.
    Shiose S; Sakamoto T; Yoshikawa H; Hata Y; Kawano Y; Ishibashi T; Inomata H; Takayama K; Ueno H
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2395-403. PubMed ID: 10937546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy.
    Burgos R; Simó R; Audí L; Mateo C; Mesa J; García-Ramírez M; Carrascosa A
    Diabetologia; 1997 Sep; 40(9):1107-9. PubMed ID: 9300249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy.
    Hogeboom van Buggenum IM; Polak BC; Reichert-Thoen JW; de Vries-Knoppert WA; van Hinsbergh VW; Tangelder GJ
    Diabetologia; 2002 Feb; 45(2):203-9. PubMed ID: 11935151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma vascular endothelial growth factor as a marker for early vascular damage in hypertension.
    Tsai WC; Li YH; Huang YY; Lin CC; Chao TH; Chen JH
    Clin Sci (Lond); 2005 Jul; 109(1):39-43. PubMed ID: 15740459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of circulating endothelial progenitor cells and vasculogenic factors in the pathogenesis of diabetic retinopathy.
    Lee IG; Chae SL; Kim JC
    Eye (Lond); 2006 May; 20(5):546-52. PubMed ID: 15905870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
    Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
    Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship among VEGF, VEGF receptor, AGEs, and macrophages in proliferative diabetic retinopathy.
    Kakehashi A; Inoda S; Mameuda C; Kuroki M; Jono T; Nagai R; Horiuchi S; Kawakami M; Kanazawa Y
    Diabetes Res Clin Pract; 2008 Mar; 79(3):438-45. PubMed ID: 18053608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy.
    Watanabe D; Suzuma K; Matsui S; Kurimoto M; Kiryu J; Kita M; Suzuma I; Ohashi H; Ojima T; Murakami T; Kobayashi T; Masuda S; Nagao M; Yoshimura N; Takagi H
    N Engl J Med; 2005 Aug; 353(8):782-92. PubMed ID: 16120858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.